RANSOMWARE VICTIMHEALTHCAREDUPLICATE CLAIM

Lampire Biological Laboratories

www.lampire.com
sinobi📍 United States (US)📅 January 5, 2026
8
same group

Attack Intelligence

Lampire Biological Laboratories was compromised in a ransomware attack attributed to sinobi in January 2026. The organization, operating in the Healthcare sector in United States, was added to the group's data leak site as part of an extortion campaign.

sinobi operates as a financially motivated ransomware-as-a-service (RaaS) operation, exfiltrating sensitive data and threatening public disclosure to pressure victims into paying ransom demands.

LAMPIRE Biological Laboratories, a pioneering biotech life science firm specializing in the creation and supply of vital biological reagents for the diagnostic and pharmaceutical industries. Our extensive offerings encompass tailor-made polyclonal and monoclonal antibody development, secondary antibodies, IgGs, BSA, animal blood, tissues, and organs. We also provide both normal and disease-state human serums and plasmas, along with cutting-edge cell media, OMNI C3 cell culture bags, contract manufacturing solutions, and an array of technical support services.

Additional Details

Other Victims — sinobi (8)

Quick Facts

CountryUnited States (US)
SectorHealthcare
Attack DateJan 5, 2026
Domainwww.lampire.com
Intel Sourceransomware.live
StatusDUPLICATE CLAIM

Threat Group

sinobi
Motivation: financial
View group profile →

External Links

Data sourced from Ransomware.live, RansomLook, and CTIWATCH OSINT collection. Victim listing does not imply confirmed breach — intelligence based on group claims.